Difference between revisions of "Category:Bispecific antibody medications"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "Category:Antineoplastic monoclonal antibodies") |
Warner-admin (talk | contribs) m |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | [[Category: | + | A class of manufactured antibodies with two targets. The most common class of bispecific antibody medications has one arm with a targeted effect on a cell surface protein and the other arm an immunostimulatory T-cell activating effect, usually through the engagement of CD3. |
| + | |||
| + | [[Category:Antibody medications]] | ||
Latest revision as of 20:54, 3 October 2023
A class of manufactured antibodies with two targets. The most common class of bispecific antibody medications has one arm with a targeted effect on a cell surface protein and the other arm an immunostimulatory T-cell activating effect, usually through the engagement of CD3.
Subcategories
This category has the following 3 subcategories, out of 3 total.